Skip to main content

Share story

Policy Products

Ireland fines Google €403 million over location-data processing

Ireland fines Google €403 million over location-data processing Image: Primary
Ireland's Data Protection Commission fined Google €403 million for GDPR violations involving location information collected through Web & App Activity, Location History and Android's Location Accuracy feature. The regulator ordered Google to bring the processing into compliance within six months. The commission found transparency failures across all three features and said Google retained some Web & App Activity and Location History data longer than necessary. Google said the case concerns historical policies that it has since changed, citing on-device Maps Timeline storage and automatic deletion of information older than three months. The regulator has not yet published its full decision.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from BleepingComputer and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...